Titan Medical has filed a patent for an instrument manipulator for a robotic surgery system. The manipulator includes a housing that supports surgical instruments and an actuator that moves the housing forward and backward. A release connected to the housing allows the user to manually retract the instruments. The manipulator also features a user interface for easy transition between manual and automated movement. GlobalData’s report on Titan Medical gives a 360-degree view of the company including its patenting strategy. Buy the report here.

Smarter leaders trust GlobalData

Report-cover

Premium Insights Titan Medical Inc - Company Profile

Buy the Report

Premium Insights

The gold standard of business intelligence.

Find out more

According to GlobalData’s company profile on Titan Medical, surgical robots was a key innovation area identified from patents. Titan Medical's grant share as of September 2023 was 53%. Grant share is based on the ratio of number of grants to total number of patents.

Instrument manipulator for robotic surgery system with manual retraction

Source: United States Patent and Trademark Office (USPTO). Credit: Titan Medical Inc

A recently filed patent (Publication Number: US20230301737A1) describes an instrument manipulator for a robotic surgery system. The instrument manipulator includes a housing that supports at least one surgical instrument and an actuator that moves the housing forward and backward. A release mechanism is connected to the housing and can engage or disengage with the actuator. When engaged, the actuator allows the housing and surgical instrument to move forward and backward in response to activation. When disengaged, the user can manually move the housing and surgical instrument backward. The instrument manipulator also includes a user interface on the exterior surface of the housing that allows the user to transition the release mechanism between the engaged and disengaged configurations, facilitating retraction of the surgical instrument away from the surgical site.

The patent also describes a method for manually retracting the instrument manipulator. The method involves activating an emergency release of the instrument manipulator to disengage it from the actuator. While the emergency release is activated, the user can manually move the instrument manipulator and the surgical instrument backward away from the surgical site. After manually retracting the instrument manipulator, the surgical instrument can be removed from the manipulator. The method also includes the option to reengage the emergency release with the actuator by releasing the button on the exterior surface of the instrument manipulator, allowing the robotic surgery system to manipulate the surgical instrument again.

Overall, this patent introduces an instrument manipulator for a robotic surgery system that allows for both automated and manual movement of the surgical instrument. The inclusion of a user interface and an emergency release mechanism provides flexibility and control to the user during surgical procedures. The method described in the patent enables the safe and efficient retraction of the instrument manipulator and surgical instrument from the surgical site.

To know more about GlobalData’s detailed insights on Titan Medical, buy the report here.

Premium Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies